NCT05097040

Brief Summary

The pilot randomized controlled trial aims to assess effects of a guided online acceptance and commitment therapy (ACT) intervention on distressed stroke survivors compared to the care-as-usual control group. A total of 24 stroke survivors who meet the inclusion criteria will be recruited and randomized to either the intervention group or the control group. Exploratory hypotheses are that the ACT group will show improvements in mental health outcomes (e.g., depressive symptoms, anxiety, and stress), and ACT processes (e.g., psychological flexibility/acceptance) at posttest and 2-month follow-up, compared to the care-as-usual control group. Also, the project will evaluate the feasibility of recruitment, adherence, and retention of participants and explore participants' experiences in the ACT intervention through semi-structured interviews at posttest.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2022

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 27, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

January 9, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 11, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 11, 2022

Completed
Last Updated

March 2, 2022

Status Verified

February 1, 2022

Enrollment Period

1 month

First QC Date

October 18, 2021

Last Update Submit

February 11, 2022

Conditions

Keywords

Acceptance and Commitment TherapyStrokeMindfulnessPsychological healthSelf-compassionDepressionAnxietyStress

Outcome Measures

Primary Outcomes (3)

  • Change from baseline to immediately after the intervention and 2-month follow-up on the Patient Health Questionnaire-9

    The Patient Health Questionnaire-9 is a 9-item questionnaire assessing depressive symptoms on a scale of 0 to 3. Scores range from 0 to 27. Higher scores indicate greater symptomatology in depression.

    Change from baseline to immediately after the intervention and 2-month follow-up

  • Change from baseline to immediately after the intervention and 2-month follow-up on the Generalized Anxiety Disorder-7

    The Generalized Anxiety Disorder-7 is a 7-item questionnaire assessing anxiety on a scale of 0 to 3. Scores range from 0 to 21. Higher scores indicate greater anxiety.

    Change from baseline to immediately after the intervention and 2-month follow-up

  • Change from baseline to immediately after the intervention and 2-month follow-up on the Perceived Stress Scale

    The Perceived Stress Scale is a 10-item questionnaire assessing stress on a scale of 0 to 4. Scores range from 0 to 40. Higher scores indicate greater stress.

    Change from baseline to immediately after the intervention and 2-month follow-up

Secondary Outcomes (7)

  • Change from baseline to immediately after the intervention and 2-month follow-up on the World Health Organization Quality of Life - Psychological health component

    Change from baseline to immediately after the intervention and 2-month follow-up

  • Change from baseline to immediately after the intervention and 2-month follow-up on the Self-Compassion Scale- Short Form

    Change from baseline to immediately after the intervention and 2-month follow-up

  • Change from baseline to immediately after the intervention and 2-month follow-up on the Patient-Reported Outcomes Measurement Information System (PROMIS) - Meaning and Purpose Short Form

    Change from baseline to immediately after the intervention and 2-month follow-up

  • Change from baseline to immediately after the intervention and 2-month follow-up on the Patient-Reported Outcomes Measurement Information System (PROMIS) Self-Efficacy for Managing Chronic Conditions - Managing Emotions - Short Form

    Change from baseline to immediately after the intervention and 2-month follow-up

  • Change from baseline to immediately after the intervention and 2-month follow-up on the Action and Acceptance Questionnaire-II

    Change from baseline to immediately after the intervention and 2-month follow-up

  • +2 more secondary outcomes

Other Outcomes (1)

  • Interviews of participants

    Immediately after completing 6 weekly ACT sessions

Study Arms (2)

Acceptance and commitment therapy (ACT) group

EXPERIMENTAL

A total of 7 ACT sessions individually guided by a trained coach through Zoom videoconferencing

Behavioral: acceptance and commitment therapy (ACT)

Control group

NO INTERVENTION

Care as usual

Interventions

The intervention group will receive individual ACT sessions guided by a trained coach for one hour per week over 6 weeks through Zoom videoconferencing. Also, a one-time 1-hour booster session will be provided at 1-month follow-up to facilitate the maintenance of treatment effects.

Acceptance and commitment therapy (ACT) group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • community-dwelling adults (aged 18 or above) with a confirmed diagnosis of stroke
  • having at least mild symptoms of psychological distress measured by the Depression, Anxiety and Stress Scale
  • having a computer or a smartphone with internet access at home
  • being able to provide informed consent by understanding the nature of study participation

You may not qualify if:

  • living in a nursing home at time of consent
  • a diagnosis of severe cognitive impairment (e.g., dementia)
  • inability to understand spoken and/or written English
  • having severe communication difficulties (e.g., aphasia and dysarthria) that can impede study participation
  • having a life-threatening illness (e.g. advanced cancer or advanced heart failure) that would make survival for 6 months unlikely
  • having a diagnosis of other central nervous system disorders other than stroke or a severe mental illness (e.g., psychosis)
  • currently receiving a psychological therapy or participating in another study that may affect mental health
  • having a prior experience in ACT
  • having psychiatric hospitalizations or diagnoses of mental illness in the previous two years
  • taking antipsychotic medication at the time of recruitment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

MeSH Terms

Conditions

DepressionAnxiety DisordersStrokePsychological Well-Being

Interventions

Acceptance and Commitment Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPersonal Satisfaction

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Areum Han, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

October 18, 2021

First Posted

October 27, 2021

Study Start

January 9, 2022

Primary Completion

February 11, 2022

Study Completion

February 11, 2022

Last Updated

March 2, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations